A phase III multicentre, prospective, randomised open-label blinded endpoint (PROBE) study: Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) study

  • Bladin, Christopher (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/13 → 1/06/17